Work

A Case of an Acquired Factor V Inhibitor Triggered by Levofloxacin and Ceftazidime and Effectively Treated With Clinical Pharmacist Assistance

Year: 2025

Type: article

Abstract: Acquired factor V inhibitor is a rare and clinically challenging condition that can manifest across a spectrum ranging from asymptomatic laboratory abnormalities to life-threatening hemorrhagic episodes. This case reports a patient with antibiotic-associated AFVI, who presents asymptomatically and may be managed conservatively with close monitoring and clinical pharmacist guidance.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.71129

Authors: Chunjuan Zhao, Weibu Chen, Xueyan Chen

Institutions: Southern University of Science and Technology, ShenZhen People’s Hospital

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820